Novartis AG raised its full-year guidance Wednesday as it reported strong growth of its newer drugs, bolstering its chief executive’s efforts to focus the pharmaceutical giant on higher-value medicines.
The Basel, Switzerland-based company said it now expects core operating income to grow by a high single-digit percentage, up from earlier guidance of a mid-to-high single digit rise. It said it continued to expect sales to increase by a mid-single-digit percentage.
Revamping his annual bonus.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
US stocks rally again to record highs as earnings smash expectations — 'Is it different this time?'Better-than-expected earnings unleashed a wave of optimism in the US, sending the S&P 500 to its 'third big high.' Asia and Europe weren't as upbeat. When the “is it different this time?” stories start it is time to het your money out because a crash is around the corner 'earnings smash expectations'. Whose earnings? The 99%ers'?
Leer más »
European shares dip as China policy concerns temper earnings boostEuropean shares pulled back from eight-month highs on Wednesday as worries over ...
Leer más »
Caterpillar is set to report earnings before the bell — here's what the Street expectsCaterpillar is reporting first-quarter earnings before the bell on Wednesday.
Leer más »
Boeing earnings expected before the bell as market looks for 737 Max newsBoeing's first-quarter earnings report is expected before the market opens on Wednesday.
Leer más »